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ABSTRACT
Microdamage is a component of bone quality believed to play an integral role in bone health. However, comparability between
existing studies is fraught with issues due to highly variable methods of sample preparation and poorly deﬁned quantiﬁcation
criteria. To address these issues, this article has two aims. First, detailed methods for preparation and analysis of linear microcracks
in human ribs, speciﬁcally addressing troubleshooting issues cited in previous studies, are laid out. Second, new, partially
validated criteria are proposed in an eﬀort to reduce subjective diﬀerences in microcrack counts and measures, ensuring more
comparable results between studies. Revised deﬁnitions based on current literature in conjunction with a digital atlas to reduce
observer inaccuracy and bias are presented. The goal is to provide a practical methodology for bone biologists and biomechanists
to collect and analyze linear microcracks for basic science research. © 2019 The Authors. JBMR Plus published by Wiley Periodicals,
Inc. on behalf of American Society for Bone and Mineral Research.
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Introduction

B

one health is a question of growing concern as our
population continues to age. Though a complicated
subject, at its most basic bone health refers to bone's ability
to maintain function. The most obvious challenge to skeletal
health is bone fracture, which undermines the skeleton's ability
to carry out all its required functions. Ubiquitous in all human
populations, fracture contributes globally to morbidity and
mortality rates; however, increased prevalence and severity in
certain demographic groups, such as the elderly and particularly elderly females, suggest that unknown risk factors in these
populations contribute to compromised bone health.(1)
Traditional diagnostic tools for assessing bone health and
fracture risk rely on bone mineral density (BMD), which
essentially measures bone mass, but an increasing body of
evidence suggests that BMD provides at best an incomplete
picture of bone health.(2–4) Clinical evidence clearly demonstrates that decreased BMD is consistent with increased
fracture risk, but there is no indication that increased BMD
results in a corresponding decrease in fracture risk.(5) Furthermore, research indicates that bisphosphonates, the most
common drug treatment for osteoporosis, halt bone loss but
do not necessarily reduce fracture risk in the long term.(6,7)

Recognizing bone mass alone as insuﬃcient to make accurate
fracture risk assessments, many clinicians have adopted tools
such as Fracture Risk Assessment Tool (FRAX), designed to
predict the 10‐year probability of fracture on the basis of
multiple clinical risk factors, in addition to BMD.(8) Among these
risk factors are demographic data such as age, sex, weight, and
height, as well as patient history including previous fractures or
secondary osteoporosis as a consequence of another disorder
(ie, diabetes mellitus, hyperparathyroidism, etc.). Although this
approach improves predictive outcomes,(8) it does so without a
thorough understanding of the basic biology driving this
variation.
As the paradigm shifts away from a strictly bone quantity
based measure in clinical assessment, bone quality has risen as a
more nuanced contender for deﬁning bone health, both in the
realm of clinicians and researchers.(9) Bone quality considers
bone's mechanical properties, both structural and material,
when trying to deﬁne health and fracture risk.(10) Among the
various components of bone quality, microdamage holds great
potential as a major contributor to variable fracture risk and
compromised bone health. Long observed in nonbiological,
engineering materials as the result of fatigue, microdamage,
usually in the form of linear microcracks, signals the imminent
failure of these materials.(11) Frost(12) was the ﬁrst to conclusively
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identify evidence of microdamage in vivo in bone. He also
proposed that these linear microcracks repair via targeted
remodeling to maintain skeletal integrity, thus explaining why
bone does not regularly fail. Since then, numerous studies have
provided support for his hypothesis,(13–15) while simultaneously
raising more questions about how microdamage inﬂuences
other mechanical properties and its role in overall bone health.
Thus, much remains to be examined to determine the relative
importance of microdamage amongst the litany of existing bone
quality components.

What is the basis of bone quality?
Bone quality encompasses skeletal integrity on multiple levels.
Though many and often poorly deﬁned, common consensus
indicates that among the most important components of bone
quality are trabecular and cortical microarchitecture, microdamage, collagen characteristics, osteocytic network viability,
and mineralization,(10,16) elements that range from the nanoscale to the macroscale of bone. More methodical approaches to
studying bone quality variables can help researchers and
clinicians improve bone health and fragility assessments, and
potentially contribute to the development of targeted treatments.
Bone is a composite material with multiscale, hierarchical
organization.(17) Like any material, bone's strength derives from
its structural organization and the material properties of its
constituent components. Each level of the hierarchy has its
own mechanical properties that form the basis of quality
assessments, which in turn contribute to the global properties
of the whole bone. The interplay between mass, geometry, and
material properties at all scales determines bone's strength and
its ability to resist loads applied to it. As a biological material,
bone is adaptive, adjusting to meet shifting mechanical
demands placed upon the body,(18) as well as restorative,
able to repair itself when damaged. This malleability makes
bone structure complex, but highly eﬀective in achieving its
functions.
Locomotion demands that bones be both strong and
ﬂexible, while remaining light enough to be energetically
eﬃcient,(10,19,20) requirements mechanistically at odds. The
solution is bones with a hollow cylindrical structure, ensuring
greater stiﬀness, but with far less mass,(21) as well as a
combination of organic and inorganic components arranged to
provide a balance between ductility and stiﬀness.(22) As a living
tissue, bone alters its structure to meet the demands of activity
as they shift throughout the lifespan.(18) Functional adaptation
does not create ideal skeletal morphology, but rather a
morphology that is likely “good enough” to survive in a given
environmental condition. Additionally, material changes to
bone aﬀected by altered physiology as the result of genetic,
metabolic, and/or environmental factors occur throughout life
and interact with structural variation.(23) These structural and
material properties and their functions, interactions, and the
changes they undergo are the basis of bone quality.

What is bone microdamage and why does it occur?
Previous research suggests that(24,25) microdamage holds
great potential for explaining diﬀerences in bone strength
and fragility among bone quality components. Damage
formed at the microscopic level of bone (ie, microdamage)
occurs in response to skeletal loading(26,27) and classiﬁes
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broadly into three types: microfractures, diﬀuse damage, and
linear microcracks. Microfractures typically occur in trabecular
bone,(26) whereas diﬀuse damage and linear microcracks are
most prevalent in the cortex.(28) Because the goal of this
review is to establish practical guidelines for assessing and
analyzing linear microcracks, we concentrate only on that
damage type here.
Linear microcracks typically occur in compression, appearing
as ellipsoidal shaped planes of separation particularly in
interstitial, extra‐osteonal areas of high mineralization within
the cortex.(26,28) Rising in both incidence and length with
increasing age, previous research attributes these changes to
increased collagen cross‐linking, greater bone mineralization,
and increased intracortical porosity and remodeling
events,(17,24,29–31) indicating that altered material properties
inﬂuence a bone's structural response. Inherent repair mechanisms that target these linear microcracks (ie, targeted remodeling) are essential to maintaining skeletal integrity,(15,32)
principally by keeping microcrack propagation in check.(33) As
linear microcracks expand, they sever the connections of the
extensive osteocytic canalicular network by shearing the
dendritic extensions of viable osteocytes, initiating osteocyte
apoptosis and activating remodeling.(34–36) As our physiological
systems falter with advancing age, elevated fragility may arise
as a consequence of damage accrual outpacing repair.
Microdamage is best understood in terms of fatigue,
whereby cyclic loading results in damage accumulation that
leads to failure at stresses below normal load thresholds. An
example would be dancers who experience lower limb stress
fractures due to excessive use.(37) However, non‐excessive loads
such as breathing, which falls within the adapted state of the
rib's mechanostat, may also fatigue bone and result in the
formation of microdamage.(38) This raises the question: if
damage formation can weaken a bone's overall strength, why
does it occur?
At its most basic level, the initiation and propagation of
microdamage increases bone toughness, dissipating the
energy of applied forces that could otherwise result in
catastrophic failure.(26,39) In addition, some microdamage is
essential to bone renewal, as repair mechanisms targeting
damaged areas eliminate the compromised areas via their
removal and replacement.(13–15) Thus microdamage serves an
adaptive role in the skeleton. The ability to initiate microdamage helps bone balance the conﬂicting demands of
stiﬀness and ductility, whereas targeted repair contributes to
maintaining the integrity required of the skeleton in long‐lived,
highly mobile species such as humans.(21)

Why study linear microcracks?
Considering the diﬀerent varieties of microdamage, why
concentrate on linear microcracks here? First and foremost
because previous research has indicated that linear microcracks
are the most detrimental to bone health and integrity.(24,25)
Diﬀuse damage is characteristic of younger tissue, as well as
chronologically younger individuals. Meanwhile, linear microcrack prevalence is greater in elderly populations, making linear
microcracks the more obvious candidate for damage contribution to skeletal fragility.
On a practical level, linear microcracks are the easiest type of
cortical microdamage to assess, as they are principally
examined via two‐dimensional (2D) methods requiring at
minimum staining capabilities and access to light microscopy.
JBMR Plus (WOA)

Current standards for diﬀuse damage analysis rely on methods
such as scanning electron microscopy because of the
submicron scale at which it occurs.(40) Additionally, there are
currently no methods for evaluating cortical microdamage of
any kind in vivo, but developing methods will likely detect the
larger linear microcracks prior to diﬀuse damage due to similar
issues of resolution.
Last, a number of studies currently exploring aspects of
microdamage accumulation already exist, but although some
researchers deﬁne their criteria for counting and measuring,
none have validated these criteria to our knowledge. Validated
criteria are essential for reliably comparing the results of studies
conducted by diﬀerent researchers in diﬀerent settings. Our
aim is to build upon the work of previous researchers while
standardizing methods that can be of use to the ﬁeld.
In order to build reliably comparable data for the analysis of
linear microcracks, the aims of this review are twofold. First, we
lay out in detail methods for preparation and analysis of linear
microcracks in human ribs, speciﬁcally addressing troubleshooting issues cited in previous studies. Building on existing
methods, the Skeletal Biology Research Laboratory (SBRL) at
The Ohio State University has honed these techniques during
the preparation of several hundred human ribs for analysis.
Here, the successful, as well as failed, methods are documented
in hopes of furthering the discipline. Second, few existing
studies expressly deﬁne how and what they include in their
microcrack counts, and among those that do, we are unaware
of any that have validated their criteria. We propose new,
partially validated criteria in an eﬀort to reduce subjective
diﬀerences in microcrack counts and measures, ensuring more
comparable results between studies. Working from existing
criteria, we present revised deﬁnitions in conjunction with a
digital atlas to reduce observer inaccuracy and bias. From this
review of the existing literature combined with our own
contributions, our goal is to provide a practical methodology
for bone biologists and biomechanists to analyze linear
microcracks.

Preparing Samples for Analysis

damage from artifactual damage due to sample preparation.
Basic fuchsin, a ﬂuorescing and ethanol‐soluble dye, is diﬀused
throughout the selected bone samples prior to processing,
permeating any open spaces in the bone so that in vivo
damage will be stained and can be distinguished from
processing damage, which occurs after staining is complete
and thus remains unstained. Concerns about dehydration
shrinking creating cracks during the staining process were
put to rest by Burr and Staﬀord's(42) validation, which found
that stained ribs had a comparable number of microcracks to
unstained controls. In the mid‐1990s, the original protocol was
revised, introducing a graded series of alcohols under vacuum
to better perfuse stain throughout the bone.(41) Despite the
existence of successful guidelines for staining, all protocols
possess issues that require trouble‐shooting with regard to the
particularities of a given project and/or laboratory. The SBRL's
protocols are based on those outlined by Burr and Hooser(41)
and tailored with the much appreciated aid of Keith Condon at
the Indiana University School of Medicine for the preparation of
human rib sections, which is the current focus of microdamage
analysis at the SBRL. The SBRL protocols are described here,
including speciﬁc measures used to address problems previously described by Burr and Hooser.(41)
Block preparation
Blocks ~2 cm in length are carefully excised from fresh (ie,
unembalmed and still ﬂeshed) ribs using a Dremel tool and
incised on the pleural and inferior vertebral end surfaces to
maintain orientation (the PIV notch). Each section is divested of
soft tissue via gentle maceration in a solution of water and
detergent in a slow cooker set at low heat for a maximum of
4 hours. Once clean, each rib section is placed in a nylon biopsy
bag with a paper label written in pencil (preferably a traditional
graphite pencil) and stapled closed. Biopsy bags are permeable,
allowing staining to occur in large batches, while maintaining the
identiﬁcation for each section. Pencil is used for specimen labels
because once infused with stain ink becomes obscured on the
paper labels, whereas once the stained labels dry, pencil remains
legible. Prior to staining, samples within their biopsy bags are
deposited in a 70% ethanol (EtOH) solution for a minimum of 48
hours. Sometimes staining cannot proceed immediately for any
number of reasons (ie, scheduling conﬂicts, waiting for a larger
batch size, etc.), in which case samples may safely remain in the
70% EtOH solution indeﬁnitely until staining can proceed.

Preparing undecalciﬁed bone sections for microdamage
analysis requires approximately 4 weeks, from initial sampling
of the bone to completed slide, as well as a fair amount of
equipment and consumables. In this paper, we review the
existing methods most often cited in the literature followed by
a detailed description of our approach, which is based upon
the methods of Burr and Hooser(41) and honed for the
preparation of human rib samples. Since 2012, approximately
1000 slides of human ribs have been prepared in the SBRL for
linear microcrack analysis, a process during which various
troubleshooting techniques have been developed and tested.
Here, current procedures for staining, embedding, sectioning,
and mounting human ribs are laid out step by step.
Additionally, a complete list of the materials and equipment
used in these procedures is provided in the Supporting
Information, Part I.

Similar to Burr and Hooser,(41) basic fuchsin obtained from J.T.
Baker (Radnor, PA, USA) is made into 1% stock solutions of 80%,
90%, or 100% EtOH. All stock solutions are made by a gradual
introduction of the basic fuchsin granules into the EtOH solutions
and then allowed to sit on an active stir plate for a minimum of
24 hours (80% and 90%) or 48 hours (100%) to ensure the dye
goes into solution. Each solution should have a volume
equivalent to a ratio of at least 10 × staining solution to bone.

Staining

Staining schedules

The most popular technique for linear microcrack analysis is en
bloc staining. First proposed by Frost(12) and later validated by
Burr and Staﬀord,(42) en bloc staining distinguishes in vivo

Following the 70% EtOH solution, samples are placed directly
into a series of graded alcohol solutions under vacuum at 20
inHg (67.7 kPa) over the course of 1 week. Burr and Hooser(41)
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highlight that density aﬀects bone's ability to uptake stain, with
poorly mineralized bone requiring reduced staining times and
highly mineralized bone requiring longer staining periods. This
requires diﬀerential staining schedules meant to prevent either
overstaining or understaining samples, and thus complicating
analysis. To address this issue, staining schedules in the SBRL are
adjusted based on the chronological age of the samples in a
given batch. Although acknowledging that age is not an ideal
indicator of bone mineralization, generally speaking, older
individuals often have a greater proportion of highly mineralized
bone compared to younger individuals. Thus, prior to staining,
samples are roughly divided into either a “Young” or “Old”
category using an arbitrary cutoﬀ age of 55 years. Having
attempted various permutations of age groups and staining
schedules, we have found that this is the simplest and most
eﬀective approach to minimize understaining or overstaining
samples, because it is of course impossible to observe the
amount of primary versus secondary bone prior to slide making
or to measure degree of mineralization.
Based on the age of the group (“Young” or “Old”), the timing
and strength of solutions used varies. The “Old” group requires
both more solutions and a longer staining schedule. For the
“Old” group, the protocol is as follows:
1. Immerse in 1% basic fuchsin in 80% EtOH for 24 hours.
2. Change solution, immerse in 1% basic fuchsin in 80% EtOH
for 24 hours.
3. Change solution, immerse in 1% basic fuchsin in 90% EtOH
for 24 hours.
4. Change solution, immerse in 1% basic fuchsin in 100% EtOH
for 48 hours.
5. Change solution, immerse in 1% basic fuchsin in 100% EtOH
for 48 hours.
6. Thoroughly rinse samples in 100% EtOH to remove excess
stain.
For the “Young” group, the protocol is the same but excludes
step 2. Though rare in the SBRL, we recommend that if the
samples in question are less than 35 years of age, step 6 also be
excluded. For all stages in any group, the samples are kept in
solution under vacuum at 20 inHg (67.7 kPa). Samples should
be periodically stirred to prevent uneven staining. To rinse the
samples, they are agitated within their biopsy bags in pure
ethanol until minimal dye is released, which is a lengthy
process.

Embedding
In order to maintain the delicate trabecular architecture of the
rib during sectioning, samples in the SBRL are embedded in
99% methyl methacrylate (MMA) immediately following
staining. MMA is the plastic of choice for many working with
undecalciﬁed bone, either stained or unstained, because its
hardness is comparable to that of bone, improving the chance
of intact sections during and after cutting.(43) Additionally,
embedded samples are easier to store and preserve long‐term
than unembedded samples.

Inﬁltration
After thorough dehydration prior to and throughout the staining
process, bone samples require an extended period of MMA
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inﬁltration prior to embedding.(43) Once thoroughly rinsed of
excess dye, the biopsy bags containing stained samples are
immersed in liquid MMA and kept under vacuum for 24 hours.
After 24 hours, samples are transferred to a solution of MMA and
4% dibutyl phthalate and kept under vacuum at 20 inHg (67.7 kPa)
for a minimum of 5 days, with the vacuum pulled at least every 24
hours. A cold trap vapor condenser should be added to prevent
MMA gases from contaminating the pump. Dibutyl phthalate
works to moderately soften the MMA and increase its elasticity.(43)
New MMA solutions are not necessary for the inﬁltration portion of
the embedding process and the same MMA is often used to
prepare numerous batches before disposal, which usually occurs
when reused MMA becomes cloudy with remnant stain from the
soaking samples.
Preparing the embedding molds
After inﬁltration, samples and labels are taken from their biopsy
bags and the PIV notch in each bone is marked with pencil to
make it easily visible through the plastic after embedding. Each
sample receives its own mold, previously labeled in pencil on
waterproof tape. When selecting embedding molds, make sure
the containers are sealable and made of either glass or a plastic
that will not react with MMA. Film canisters are recommended
because they have tight caps and are cheaply acquired. Molds
should be previously prepared with an MMA base of ~5 mm to
prevent samples from resting on the bottom of the mold and
thus allowing them to be fully suspended in MMA.
Embedding procedure
An initiator is required to create the catalyzed MMA to embed
the sample. A solution of new MMA and 4% dibutyl phthalate is
mixed with 0.25% Perkadox and thoroughly stirred to activate
the solution. As MMA cures, it shrinks, so each container must
be ﬁlled with suﬃcient catalyzed MMA to more than cover the
samples (for our samples, ~10 mL) in order to ensure that the
bone remains fully covered once the MMA has set. Any excess
activated MMA can be used to create bases in empty molds for
future rounds of embedding.
Filled molds are left uncovered under vacuum at 20 inHg
(67.7 kPa) for at least 12 hours, then they are sealed and
refrigerated overnight. Once cooled, the sealed molds enter a
water bath at room temperature, ensuring the water line rests
above the contents of the canisters, and the temperature is
gradually increased at a rate of 0.3°C every hour until reaching
37°C. At that point, the molds are taken from the water bath
and the lids removed to conﬁrm that the MMA has set. If the
MMA is still not solid, the molds are resealed and placed back in
the water bath until the MMA sets. When the MMA has set,
open molds are placed in an oven at 60°C and cured overnight.

Sectioning blocks
Once cured, embedded sample blocks are cut free and the
molds discarded. Tape labels from the discarded molds are
transferred to the MMA blocks themselves. Using the PIV notch
as a guide, orientation labels are written on the surface of each
block (ie, P = pleural, I = inferior, V = vertebral) to maintain
orientation during sectioning.
Traditional preparation of undecalciﬁed sections calls for
sectioning at a thickness of 250 to 500 µm, then manually
JBMR Plus (WOA)

grinding samples to 30 to 150 µm (exact measures vary by
study).(12,35,42) Sections are most often cut using a diamond blade
wafering saw and ground on a turntable‐style grinder until
reaching the desired thickness. Although cutting and grinding may
introduce artifactual microdamage, such instances are excluded
from counts and analysis by eliminating cracks that are not stained
through the depth of the section. However, the use of a diamond
wire saw allows sectioning of undecalciﬁed material at a thickness
of ~70 to 125 µm and eliminates grinding from the slide‐making
process, reducing the opportunity for artifactual damage formation. The SBRL uses a Delaware Diamond Knives, Inc. (Wilmington,
DE, USA) diamond wire saw with a 0.22‐mm‐diameter diamond
wire to prepare sections for slides. Distilled water is used to keep
samples hydrated, preventing the dissolution of the dye and
keeping stain contained to the porous locales in the bone.
Undecalciﬁed tissue sections, even at 120 µm, often curl
when drying. Thus, once cut, sections are wrapped in a
Kimwipe and pressed between two slides with binder clips for
at least 48 hours (timing varies depending on the ambient
temperature and humidity). This removes excess moisture
absorbed during sectioning and ensures that sections dry ﬂat,
considerations that ease the slide making process. To maintain
orientation of the sections throughout processing, it is
recommended that a consistent corner of the embedding
material be clipped (ie, inferior/pleural corner) prior to pressing.

Mounting slides
After pressing, sections are mounted on 1 × 3 inch glass slides
with etched labels. The dried, ﬂat sections are trimmed of excess
MMA and cleared in xylene prior to mounting. As a mounting
medium, the SBRL currently uses Eukitt® (Germany) for its quick
curing time, its long‐term preservation, and because it helps
maintain stain. Mounting media with long curing times often
lead to bubble formation beneath the coverslip, which can
compromise slide utility, and long‐term preservation with many
media is poor, often yellowing and/or crystallizing so that slides
must be remounted within 5 years. Being sure to permeate the
bone, three drops of mounting medium are used to coverslip
sections. Slides are left to lie ﬂat in dark drying trays for a
minimum of 2 weeks. Though slides can be imaged and analyzed
immediately, the 2‐week drying period ensures that the
mounting medium fully cures, preventing bubble formation
beneath the coverslip. When not in use, slides should be stored in
a cool, dry, dark place for best preservation.

computing power available. Two considerations for any
imaging regardless of these features, magniﬁcation and
illumination, are presented here.
Magniﬁcation
Selecting magniﬁcation for data collection depends on the data
to collect and the quality of the camera available. The smaller
the feature, the higher the imaging resolution needed for
accuracy.
For microcrack analysis in the SBRL, ribs are analyzed and
imaged at ×200 magniﬁcation. Previous studies used a variety
of magniﬁcations for microdamage analysis, though most fall
between ×150 and ×200 (see Table 1). Based on reported
average lengths, this appears to be suﬃcient resolution to
capture most visible linear microcracks and allows our data to
be more directly comparable to existing studies (see Agnew
and colleagues(44) for a more detailed discussion of how
magniﬁcation diﬀerences may inﬂuence linear microcrack
quantiﬁcation).
The disadvantage of such high‐resolution photography is the
size of generated image ﬁles. For example, a complete human
rib at ×200 magniﬁcation can result in a 2‐Gb tag image ﬁle
format (TIFF) ﬁle. As technology advances, such concerns may
become obsolete, but this is not currently the case. Although
microcrack analysis can be carried out imaging only regions of
damage, such a piecemeal approach is untenable for measuring cross‐sectional geometry variables. Complete cross‐
sectional images are preferred, but because these variables
are larger, the images can easily be taken at lower magniﬁcations (eg, ×40, ×100), signiﬁcantly reducing ﬁle sizes. Data are
comparable across images as long as appropriate scales are
included.
Illumination

Conducting accurate and detailed analyses of linear microcracks in 2D is best done through a combination of high‐
resolution still images and live observation on the microscope.
This section provides recommendations for imaging basic
fuchsin‐stained slides, revised classiﬁcation criteria, and partial
validation results, and considerations for data collection using
still images. Though developed on human ribs, the information
and techniques described here apply to linear microcrack
analyses of any skeletal element.

Bright ﬁeld and ﬂuorescent lighting each have advantages and
are often used together, both for imaging and live microscopy
in the SBRL. Although microcrack analysis can be and is
conducted using bright ﬁeld illumination, Lee and colleagues(45) showed that the use of FITC ﬂuorescence can improve
an observer's ability to see and assess microdamage when
using basic fuchsin to stain bone. Pink in bright ﬁeld
illumination, basic fuchsin appears deep orange/red when
viewed under ﬂuorescence. Thus regions of the bone inﬁltrated
by basic fuchsin stand out against those that have not
absorbed any stain, which appear green under FITC ﬂuorescence (Fig. 1). This can be especially helpful to those new to
linear microcrack analysis, because ﬂuorescence emphasizes
the contrast between potential microcracks and the surrounding bone more so than bright ﬁeld illumination. Although
identifying potential microcracks is easier with ﬂuorescence,
conﬁrming that microcracks open on the surface of a section
(see Classiﬁcation criteria) is easiest in bright ﬁeld, live on the
microscope. For the most accurate results, analysts should
combine imaging with live microscopy and actively use both
bright ﬁeld and ﬂuorescent illumination if possible.

Imaging

Histomorphometric variables

Many factors inﬂuence the success of imaging for data analysis,
including slide quality and the camera, microscope, and

Histomorphometry is an essential tool for 2D microdamage
studies using quantitative methods to analyze bone micro-
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Table 1. Magniﬁcations, Illuminations, Bones, and Sampling Regions for Some Linear Microcrack Analyses From the Literature
Reference

Magniﬁcation

Illumination

Bone

Sampling

(1960)
Frost
Burr and Staﬀord(42) (1990)
Schaﬄer and colleagues(61) (1995)

a

×50
×100
×200

BF
BF
BF

Human rib
Human rib
Human femur

Boyce and colleagues(62) (1998)

×125

BF

Human tibia

×150
×125, ×225
×125, ×250
×200
×125
×125
×400
×400

BF
BF, FL
BF, FL
BF
BF
BF
BF (?)
FL

Dog femur
Human rib
Dog femur
Rat ulna
Bovine tibia
Human tibia
Rat ulna
Human rib

Complete cross‐section
Complete cross‐section
Principal anatomical axes
(anterior, poster, medial, lateral)
Beam cross‐sections representing
tensile, neutral axis, and
compressive regions
Complete cross‐section
Complete cross‐section
Complete cross‐section
Complete cross‐section
Anterior quadrant
Anterior and posterior cortices
Complete cross‐section
Complete cross‐section

(12)

Burr and colleagues(50) (1998)
Lee and colleagues(45) (1998)
Huja and colleagues(63) (1999)
Danova and colleagues(51) (2003)
Diab and Vashishth(57) (2005)
Diab and Vashisth(28) (2007)
Herman and colleagues(35) (2010)
Agnew and colleagues(44) (2017)

BF = bright ﬁeld; FL = ﬂuorescent lighting.
a
Magniﬁcation based on ﬁgure legends because the magniﬁcation for analysis is never expressly stated in the text.

architecture. Microdamage quantiﬁcation occurs in diﬀerent
ways from classiﬁcation by type and location (eg, diﬀuse versus
linear microcracks, lamellar versus interstitial bone, etc.(28,46)) to
assessment in relation to features such as porosity or lacunar
density,(47,48) and even measuring the displacement of crack
openings.(49) The most common approach is simple counts and
measures of linear microcracks and their areal densities.(30,47,49–53) Four variables are commonly used in linear
microcrack studies: crack number (Cr.N), crack length (Cr.Le),
crack density (Cr.Dn), and crack surface density (Cr.S.Dn). These
variables and other common histomorphometric measures
used in damage analysis are listed and deﬁned in Table 2. Two
of these variables, Cr.N and Cr.Le, are direct observations

usually taken from images, whereas Cr.Dn and Cr.S.Dn must be
calculated using Cr.N and Cr.Le in combination with a measure
of bone area.
When comparing data across individuals, density variables
are particularly useful, because the inclusion of bone area acts
as an allometric control. Most literature uses cortical area (Ct.Ar,
called “bone area” in some papers, though a distinction is made
between those variables here) to calculate areal densities,
which is deﬁned as the total cortex examined, including
porosity present within the deﬁned boundaries. These boundaries may refer to anything from complete cross‐sections of a
bone to a fraction of the cortex. In the ribs, Ct.Ar is calculated
by taking the total subperiosteal area of a cross‐section and

Fig. 1. A stained linear microcrack highlighted by a white arrow. The image on the left is under bright ﬁeld illumination, whereas the image on the
right was photographed under FITC ﬂuorescence. The dark pink color in the left image is the basic fuchsin permeating the open spaces, which
appears red and in stark contrast to the unstained green portions of the bone in the right image.
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Table 2. Histomorphometric parameters important for linear microcrack analysis in the ribs
Parameter name

Abbreviation

Total area

Tt.Ar

Endosteal area

Es.Ar

Cortical area
Pore area

Ct.Ar
Po.Ar

Bone area
Crack number
Crack lengthb

B.Ar
Cr.N
Cr.Le

Crack densityc

Cr.Dn

Crack surface densityc

Cr.S.Dn

Deﬁnition

Unit

Total area below the periosteum, including
mm2
the medullary cavity
Total area below the endosteum
mm2
(ie, the medullary cavity)
Area of all cortical bone, including pores
mm2
The sum of the area of all pores
mm2
(ie, Haversian canals, resorption spaces)
Area of all cortical bone, excluding pores
mm2
Count of observed linear microcracks
#
A minimum length of measure for each
μm
linear microcrack
Areal density of cracks normalized by a
#/mm2
speciﬁed bone area
Surface area occupied by cracks over a
μm/mm2
speciﬁed bone area

Formulaa
NA
NA
Tt.Ar – Es.Ar
∑Pore1 + Pore2 + … +
Porex
Ct.Ar – Po.Ar
NA
NA
Ct.N/B.Ar
Cr.N*meanCr.Le/B.Ar

a

The formula used to calculate the derived variables using the observed variables in this table are provided.
In analysis, mean Cr.Le is generally used, rather than each individual Cr.Le.
c
In most literature, areal densities for linear microcracks are calculated using the variable Ct.Ar; however, we propose the use of B.Ar as a more
accurate indicator of damage density.
b

removing the endosteal area (Fig. 2). Although valuable in
many respects, this measure fails to account for intracortical
bone loss in the form of porosity, a major concern in the rib
especially. Porosity in the cortex consists primarily of bone's
vascularizing channels, the Haversian canals, and the resorption
spaces that result from osteoclastic activity. In the rib, elevated
remodeling and high sensitivity to metabolic changes can
result in substantial bone loss within the cortex that Ct.Ar does
not measure.(54) An alternative variable, bone area (B.Ar),
calculated by removing porosity area from the cortical area,
more accurately reﬂects the amount of bone present.
Preliminary study in a sample of 10 elderly individuals indicated
that Ct.Ar and B.Ar diﬀer signiﬁcantly, implying that intracortical
porosity comprises a signiﬁcant part of the “area” measured in Ct.
Ar.(55) Considering this, B.Ar's more precise measure of viable
cortex may better represent the impact of microdamage on bone
fragility than Ct.Ar.(55) This concern is particularly relevant when
viewed in light of evidence showing existing pores as potential
stress raisers.(48) Furthermore, in microdamage studies, accounting
for intracortical porosity may signiﬁcantly inﬂuence areal density
measures of microcracks. Because calculating bone area requires
the time‐consuming collection of porosity measurements, further
exploration of the diﬀerences between these variables is needed
and is currently underway in the SBRL.

were laid out by Frost(12) (Table 3), in an eﬀort to reduce the
inherent subjectivity he recognized in microcrack assessment.
Since then, however, most papers provide perfunctory descriptions
at best of what they count as a microcrack, often citing “linear
structures”(51) or “a sharply deﬁned line”(57) as the only qualiﬁer for
their data collection. The aims of this section are not to impugn
the valuable work of prior researchers, but establishing clear
criteria for identifying, counting, and measuring linear microcracks
can aid in improving the reliability of data collected by observers
of various experience levels, regardless of sample preparation, as
well as increasing repeatability internally and between researchers.
Thirty years after Frost's(12) initial guidelines, Burr and
Staﬀord's(42) validation of the en bloc staining method included
an updated set of criteria for counting microcracks (Table 3).
The criteria presented in the current study are based in part on
the deﬁnitions laid out by Frost(12) and Burr and Staﬀord,(42) but
include considerations designed to further reduce subjectivity
in counting and measuring. In addition to the written
descriptions provided here, a photographic atlas composed
of representative images illustrating the criteria outlined in
Table 4 can be found in the Supporting Information, Part II.
Partial validation study

As stated in the Staining section above, basic fuchsin indiscriminately inﬁltrates the open spaces within bone, including not only
microdamage, but also Haversian systems, Volkmann canals, and
canalicular networks. As such, accurately distinguishing microdamage from other features of bone microarchitecture requires
familiarity with bone histomorphology. Although some studies
have used chelating ﬂuorochromes that selectively bind to
microcracks and ease identiﬁcation,(56) such methods are still rare
and do not resolve some of the quantiﬁcation issues inherent in
microcrack analysis. Speciﬁcally, few researchers are explicit in how
they determine what to include or exclude as linear microcracks.
The earliest guidelines for what should “be accepted as a crack”

To assess whether the reﬁned criteria improve precision within
observers, a sample of 10 human rib cross‐sections prepared
for linear microcrack analysis were examined. Slides were
prepared and imaged following the protocols laid out above. A
single observer, proﬁcient in bone histology, with over 7 years
of experience, but a novice in linear microcrack analysis read
each slide twice to assess intraobserver error. Readings
occurred a minimum of 2 months between observations.
Cr.N and Cr.Le were assessed at ×200 magniﬁcation and
annotated on previously taken photographs of the ribs under
ﬂuorescence. Diﬀerences between the observer's ﬁrst and second
reads were assessed by calculating the measurements' coeﬃcient
of variation (CV). CV is a standardized measure, usually given as a
percentage, of dispersion around the mean calculated as follows:
standard deviation/mean * 100. To assess the precision of the
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revised criteria, the CV of each of the 10 subjects was calculated
and rates were deemed acceptable when below 10%.
CVs greater than 10% were found for four subjects in Cr.N and
two subjects in Cr.Le (Tables 5 and 6). For Cr.N, in all instances of
CVs greater than 10%, the number of cracks counted in the second
read was higher than on ﬁrst observation. The ﬁrst read of the
slides was also the observer's ﬁrst ever experience reading
microcracks. By the time of the second slide reading, two months
of exposure to slide reading had transpired, improving the
observer's familiarity and ability to identify microcracks. The fact
that over one‐half of the slides read were within the acceptable
margin indicates that the criteria are useful for internal consistency
in a novice analyst. The consistent increase in counts between
reads suggests there is a learning curve for assessing linear
microcracks, but this must be further explored. The same pattern
was not observed in Cr.Le; however, both instances of signiﬁcant
deviation were in slides with low crack densities. Overall, the
criteria presented here are promising, but require full‐scale testing,
incorporating multiple observers with diﬀering degrees of
experience in microcrack analysis to be fully validated.

Quantiﬁcation using images
Although use of live microscopy to ensure accurate data
collection cannot be emphasized enough, quantiﬁcation of
histomorphometric data often relies on measuring photographic images. Methods for data collection from still images
are brieﬂy described in the subsequent sections.

Data collection software
Fig. 2. Calculating cortical area. Example of a human rib cross‐section
demonstrating how to calculate Ct.Ar. First, the Tt.Ar of the cross‐
section is measured, including everything below the periosteal border.
Second, the Es.Ar is measured, which is essentially the area of the
medullary cavity. Finally, the Es.Ar is subtracted from the Tt.Ar,
resulting in the total area of the cortex (Ct.Ar). Ct.Ar = cortical area; Tt.
Ar = total area; Es.Ar = endosteal area.

Although many software options for collecting data exist, most
histomorphometric analysis in the SBRL uses NIH‐funded
ImageJ.(58) ImageJ is freely available online and widely used by
a number of laboratories, allowing easy and reliable comparison
of data between researchers. Furthermore, creating region of
interest (ROI) sets in ImageJ allows users to amass large datasets
without duplicating large image ﬁles and consuming valuable
storage space. Essentially overlay ﬁles, ROI sets can store a large
number of adjustable selections for a given image at a fraction of

Table 3. Linear Microcrack Criteria as Deﬁned in the Literature
Reference
(12)

Frost

Criteria

(1960)

Must be stained through the depth of the section
Must open visibly onto the surface of the section
No permeation of stain into the bony substance in the walls of the crack

Burr and Staﬀord(42) (1990)
[used by Lee and colleagues(45) (1998);
O’Brien and colleagues(25) (2005)]

Intermediate in size, larger than canaliculi but smaller than vascular channels
Sharp borders with a halo of basic fuchsin staining around them
Stained through the depth of the section
When the depth of focus is changed, the edges of the crack are more deeply
stained than the intervening space

Schaﬄer and colleagues(61) (1995)
Frank and colleagues(30) (2002);
Danova and colleagues(51) (2003)

Linear structures with basic fuchsin staining within cracks
Linear structures with basic fuchsin staining around the cracks

Diab and Vashishth(57) (2005)

Sharply deﬁned line

Herman and colleagues(35) (2010)

Linear regions of basic fuchsin uptake with sharp boundaries
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Table 4. Linear Microcrack Criteria

Linear microcrack measures in ImageJ

• A linear microcrack is a sharply deﬁned line with a halo of
basic fuchsin. Linear microcracks are more robust in
appearance than canaliculi, which often resemble a spider
web crisscrossing the bone, but smaller than vascular
channels such as Volkmann’s canals, which are wider.
• Only cracks that visibly open on the surface of the section
being analyzed should be counted. When viewed under
the microscope, the feature in question should be counted
if it appears to open when the depth of focus is changed; if
not, it should be excluded. This is best seen in bright ﬁeld.
• Microcracks that are not artifactual will be stained through
the depth of the section, appearing darker than the
surrounding area.
• Single cracks that are distinguishable from tip to tip
should be counted as one. Length measurements should
follow the path of the crack.
• In some cases, cracks appear to coalesce, resulting in what
looks like tree branching. In these instances, the longest
axis should be counted as one and measured as the
primary crack. Branches should be counted as
independent cracks, with each branch measured from the
point of intersection with the primary crack to their
free end.
Additional criteria
• Microcracks are sometimes seen to be partially stained.
This is attributed to one of two causes: (1) the stain did not
fully impregnate the existing microcrack during the
staining process, or (2) the existing microcrack continued
to propagate during the process of slide preparation after
the staining process was completed, resulting in a portion
of the microcrack being unstained.
(1) If the crack is not stained through the depth of the
section, do not count it.
(2) If a part of the crack is stained through the depth of the
section, the microcrack should be counted, but only the
stained portion should be measured.
• Debonding of lamellar layers presents with a similar
appearance to linear microcracks. This is generally seen
between layers of concentric lamellae (within secondary
osteons) or longitudinal layers of lamellar apposition (at
the periosteal borders of the bone). Debonding should not
be counted as microcracks, with two exceptions.
(1) If the plane of separation is great enough that it appears
open on the surface of the section, it should be counted and
measured. This is most reliably determined live on the
microscope.
(2) If the microcracks run into and propagate through such
planes of separation, it should be counted. This happens
most often when microcracks break through or deﬂect
around an osteon’s reversal line.
• Instances where a series of ﬁne lines that are diﬃcult to
distinguish are seen to run through each other are known
as cross‐hatching. Damage that bears a cross‐hatched
appearance is not open to the section surface and cannot
be reliably traced, and therefore should not be counted in
linear microcrack assessment.

The SBRL method for collecting linear microcrack data using
ImageJ is brieﬂy described here. The slide is assessed on the
microscope and all observed microcracks on the entire cross‐
section are annotated on the corresponding image ﬁle within
the software. The segmented or freehand line selection tools
are used to trace the path of observed microcracks, with each
crack traced and recorded independently. Occasionally, multiple cracks appear within a microscopic ﬁeld and are not in the
same plane of focus on the reference image. In such instances,
additional photographs are taken, adjusting the camera's focus
so that the visible microcrack is sharply deﬁned and can be
accurately measured. Any additional photography is denoted
on the reference image. Counts and measures of microcrack
data are then combined for each rib prior to data analysis.

Considerations for Linear Microcrack Work
When staining en bloc, is it more detrimental to
understain or overstain?
Although achieving a perfect stain is desired, in reality there is
no guarantee. Overstaining, due either to too high a stain
concentration or too long soaking in stain, can make slides
diﬃcult to read. As noted, basic fuchsin does not preferentially
stain microcracks, so any pores and regions of collagenous
matrix can take up high quantities of stain, making distinguishing damage from cortex diﬃcult, especially under
ﬂuorescent illumination (Fig. 3). On the other hand, slides
that fail to soak in solution for enough time may result in
sections which do not absorb any stain, creating artiﬁcially low
microdamage measures. Thus, it seems preferable to err on the
side of overstaining rather than understaining.

What causes stain to appear patchy and uneven in some
sections?
Stain uptake can be irregular due to irregular mineralization in
the cortex. When this is the case, there is no solution we are
aware of, though it does convey some information about the
bone health of the individual in question. More often, this
patchy appearance likely results from poorly mixed staining
solutions. To prevent this, it is essential to dissolve basic fuchsin
crystals as completely as possible and to agitate samples within
the staining solution periodically during staining.
If this patchiness is not present at the creation of the slide,
but develops over time, it indicates too much light exposure.
Exposure to concentrated ﬂuorescent lighting for too long can
cause photo bleaching in stained sections. Essentially, the basic
fuchsin is burned out of the section, making it useless for
microdamage analysis. It is extremely important to keep
stained slides stored in the dark and to limit their light
exposure during analysis.

How important is section thickness for analysis?

the digital space required by permanently annotated images.
Last, ImageJ allows the creation and use of customized macros
and plug‐ins, which can simplify data collection. Detailed
information on the use of ImageJ ROI sets and customized
macros for histomorphometric analysis can be found in
Dominguez and Agnew.(59)

First and foremost, when dealing with histological methods
we must remember that we are using 2D methods to assess
three‐dimensional (3D) structures. Though dubbed linear
microcracks, these defects are 3D pockets within the greater
microarchitecture of the bone.(60) In 2D, we see only their
length in a single plane. Furthermore, clarity under
magniﬁcation is largely determined by section thickness;

JBMR1 Plus (WOA)

GUIDELINES FOR 2D LINEAR MICROCRACK ANALYSIS

9 of 12 ◼

When studying linear microcracks, should cortical
porosity be measured?

Table 5. Intraobserver CVs for Cr.N
Sample
1
2
3
4
5
6
7
8
9
10

Read 1

Read 2

CV

30
2
31
35
13
21
5
101
25
43

30
2
66
46
14
25
8
107
35
43

0.00
0.00
36.08
13.58
3.70
8.70
23.08
2.88
16.67
0.00

CV values in bold are above the 10% threshold for acceptable error.
CV = coeﬃcient of variation; Cr.N = crack number.

Table 6. Intraobserver CVs for Cr.Le
Sample

Read 1

Read 2

CV

1
2
3
4
5
6
7
8
9
10

0.0427
0.0966
0.0463
0.0485
0.0246
0.0482
0.0488
0.0510
0.0545
0.0504

0.0402
0.0290
0.0446
0.0431
0.0451
0.0519
0.0536
0.0557
0.0466
0.0444

3.12
53.80
1.83
5.91
29.34
3.61
4.64
4.46
7.72
6.28

CV values in bold are above the 10% threshold for acceptable error.
CV = coeﬃcient of variation; Cr.Le = crack length.

As mentioned in the discussion of histomorphometric variables,
when examining linear microcracks in the context of the
human rib, cortical porosity should be accounted for. However,
further exploration of this question is necessary, particularly in
the context of bones besides the ribs, which are less abjectly
inﬂuenced by diﬀerences in metabolism and thus less prone to
elevated intracortical bone loss.

What other techniques can be used to explore
microdamage?
Many methods other than light microscopy can be used to explore
similar questions to those detailed here. It is established that
examining diﬀuse damage requires more high‐powered microscopy, such as scanning electron microscopy (SEM). SEM allows the
submicron measurements essential to conﬁrm the presence of
diﬀuse damage, which cannot be conclusively identiﬁed with light
microscopy. It will be interesting to see if greater microscopic
resolution can improve the reliability of interobserver and
intraobserver diﬀerences.
Other imaging modalities, particularly those that rely on
nondestructive 3D scanning of skeletal material, will be
essential for understanding the role of linear microcracks in
skeletal integrity and in living populations. Currently, synchrotron scanning, which is limited to very small samples, is the
only variant of this technology with suﬃcient resolution to
examine such features. However, as the resolution of micro–
computed tomography (µCT) and clinical CT systems increases,
these methods will be essential in translating bone microarchitectural research from the laboratory to the clinical setting.

Summary
the thinner the section, the better light can pass through it
on the microscope, the clearer the image. Most researchers
use sections between 30 and 150 µm thick for microcracks
studies, so it is best to use sections within that range for
comparability. However, further work on the importance of
section thickness and serial sections is needed.

Bone’s dynamic nature makes deﬁning the importance of bone
quality components a challenge and the role of microcracks
demands further attention, but objective, repeatable methods
are essential to move microdamage research forward. Basic
fuchsin staining currently dominates linear microcrack analysis,

Fig. 3. Image of an overstained bone that is imaged under ﬂuorescence. The excess of stain makes it diﬃcult to distinguish ﬁne features in the bone.
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but although there exists a variety of methods for sample
preparation and data collection, available guidelines are few
and often sparse in detail. With this in mind, this work provides
a review of existing methods for linear microcrack analysis and
provides a step‐by‐step guide for sample preparation and
recommendations for data collection useful to anyone seeking
to enter microcrack research. As described here, reliable
staining methods are necessary to accurately capture and
quantify bone microdamage, and the approach presented here
has been reﬁned over the course of years and successfully used
on hundreds of rib samples. Establishing objective criteria for
microcrack analysis with greater repeatability within and
between observers improves research, and ultimately contributes to superior clinical approaches. Presented here are new,
partially validated criteria to reduce subjectivity in linear
microcrack analysis and increase comparability across studies.
In addition, a photographic atlas can be found in the
Supporting Information, Part II, to illustrate these criteria and
to serve as a reference for further research.
The foundations of microdamage research are well laid and
have been pivotal in demonstrating that microdamage forms
and accumulates in bones due to loading and that accrued
damage negatively aﬀects bone strength. However, many
questions remain, particularly, what role, if any, do linear
microcracks play in skeletal fragility? Future work should
explore “normal” in vivo damage across ages and sexes and
consider the contribution of preexisting damage to bone
behavior and material properties in injurious circumstances.
Though current knowledge suggests that microdamage may
contribute to the variance in bone material properties that
leads to skeletal fragility, there is little direct evidence for this at
present. Detailed analyses examining microcrack accrual
relative to tested material properties, as well as cross‐sectional
analysis of the spatial distribution of microdamage and other
microarchitectural variables (ie, porosity, remodeling) may
elucidate the loading and repair history of bone. Ultimately,
understanding how microdamage acts in the context of
skeletal longevity and fragility has signiﬁcant clinical implications that may potentially impact how we diagnose and treat
conditions in those of compromised bone health, such as those
with osteopenia and osteoporosis, among others. Exploration
of these and other questions requires reliable and replicable
methods of sample preparation and data collection to fully
capture extant microdamage. We hope the pragmatic approach presented here can work as a step toward increased
method standardization and will be welcomed by bone
biologists and biomechanists interested in expanding the ﬁeld
of bone microdamage.
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